Skip navigation

CSL Ltd.

Pharmaceuticals
Australia
2016 Revenue (US$ Millions)$5,910
Revenue Growth (%)8.26%
Net Income (US$ Millions)$1,242
Earnings Per Share (US$)$2.68
EPS Growth Rate (%)-7.93%
Profit Margin21.02%
Total Equity (US$ Millions)$2,567
Return on Equity (%)45.23%
Long Term Debt (US$ Millions)$3,081
Debt To Equity Ratio (%)1.20%
Total Assets (US$ Millions)$7,563
Current Assets (US$ Millions)$3,818
Current Liabilities (US$ Millions)$1,374
Cost of Goods Sold (US$ Millions)$3,035
Inventory Turnover1.55